Clinical activity of sorafenib in patients with advanced gastrointestinal stromal tumor bearing PDGFRA exon 18 mutation: a case series

被引：8
|
作者：
Roubaud, G. [1 ]
Kind, M. [2 ]
Coindre, J. -M. [3 ]
Maki, R. G. [4 ]
Bui, B. [1 ]
Italiano, A.
机构：
[1] Inst Bergonie, Dept Med Oncol, Bordeaux, France
[2] Inst Bergonie, Dept Radiol, Bordeaux, France
[3] Inst Bergonie, Dept Pathol, Bordeaux, France
[4] Mem Sloan Kettering Canc Ctr, Dept Med & Pediat, Sarcoma Serv, New York, NY 10021 USA
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷 / 03期
关键词：
IMATINIB MESYLATE; KINASE INHIBITOR; MUTANTS; PKC412;
D O I：
10.1093/annonc/mdr631
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：804 / +
页数：2
相关论文
共 50 条
  • [1] Avapritinib in unresectable or metastatic gastrointestinal stromal tumor with PDGFRA exon 18 mutation: safety and efficacy
    Henriques-Abreu, Miguel
    Serrano, Cesar
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2021, 21 (10) : 1081 - 1088
  • [2] Response to sunitinib of a gastrointestinal stromal tumor with a rare exon 12 PDGFRA mutation
    Brohl, Andrew S.
    Demicco, Elizabeth G.
    Mourtzikos, Karen
    Maki, Robert G.
    [J]. CLINICAL SARCOMA RESEARCH, 2015, 5
  • [3] BUDGET IMPACT ANALYSIS OF AYVAKIT (AVAPRITINIB) IN PATIENTS WITH GASTROINTESTINAL STROMAL TUMORS AND A PDGFRA EXON 18 MUTATION
    Proudman, D.
    Miller, A.
    Nellesen, D.
    Gomes, A.
    Mankoski, R.
    Norregaard, C.
    Sullivan, E.
    [J]. VALUE IN HEALTH, 2020, 23 : S38 - S38
  • [4] Clinical activity of regorafenib in PDGFRA-mutated gastrointestinal stromal tumor
    Grellety, Thomas
    Kind, Michele
    Coindre, Jean-Michel
    Italiano, Antoine
    [J]. FUTURE SCIENCE OA, 2015, 1 (04):
  • [5] Clinical characteristics and treatment outcome in a large multicenter observational cohort of pdgfra exon 18 mutated gastrointestinal stromal tumor (GIST) patients.
    Farag, Sheima
    Somaiah, Neeta
    Choi, Haesun
    Heeres, Birthe
    Wang, Wei -Lien
    Van Boven, Hester
    Nederlof, Petra M.
    Benjamin, Robert S.
    van der Graaf, Winette T. A.
    Grunhagen, Dirk J.
    Boonstra, Pieter
    Reyners, An K. L.
    Gelderblom, Hans
    Steeghs, Neeltje
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [6] Clinical activity of avapritinib in ≥ fourth-line (4L+) and PDGFRA Exon 18 gastrointestinal stromal tumors (GIST)
    Heinrich, Michael C.
    Jones, Robin L.
    von Mehren, Margaret
    Bauer, Sebastian
    Kang, Yoon-Koo
    Schoffski, Patrick
    Eskens, Ferry
    Mir, Olivier
    Cassier, Philippe
    Serrano, Cesar
    Tap, William D.
    Trent, Jonathan C.
    Rutkowski, Piotr
    Patel, Shreyaskumar
    Chawla, Sant P.
    Meiri, Eyal
    Zhou, Teresa
    Roche, Maria
    George, Suzanne
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [7] Clinical activity of avapritinib in ≥ fourth-line (4L+) and PDGFRA Exon 18 gastrointestinal stromal tumors (GIST).
    Heinrich, Michael C.
    Jones, Robin Lewis
    von Mehren, Margaret
    Bauer, Sebastian
    Kang, Yoon-Koo
    Schoffski, Patrick
    Eskens, Ferry
    Mir, Olivier
    Cassier, Philippe Alexandre
    Serrano, Cesar
    Tap, William D.
    Trent, Jonathan C.
    Rutkowski, Piotr
    Patel, Shreyaskumar
    Chawla, Sant P.
    Meiri, Eyal
    Zhou, Teresa
    Mamlouk, Khalid Kevin
    Roche, Maria
    George, Suzanne
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [8] Individualized surgical treatment in patients with advanced gastrointestinal stromal tumor - a case series
    Pytlos, Jakub
    Palucki, Jakub
    Lenarcik, Malgorzata
    Pierzankowski, Ireneusz
    Klimczak, Anna
    Olesinski, Tomasz
    [J]. ONCOLOGY IN CLINICAL PRACTICE, 2023, 19 (05): : 384 - 388
  • [9] Clinical characteristics and treatment outcome in a large multicentre observational cohort of PDGFRA exon 18 mutated gastrointestinal stromal tumour patients
    Farag, Sheima
    Somaiah, Neeta
    Choi, Haesun
    Heeres, Birthe
    Wang, Wei-Lien
    van Boven, Hester
    Nederlof, Petra
    Benjamin, Robert
    van der Graaf, Winette
    Grunhagen, Dirk
    Boonstra, Pieter A.
    Reyners, Anna K. L.
    Gelderblom, Hans
    Steeghs, Neeltje
    [J]. EUROPEAN JOURNAL OF CANCER, 2017, 76 : 76 - 83
  • [10] Clinical Activity of Ripretinib in Patients with Advanced Gastrointestinal Stromal Tumor Harboring Heterogeneous KIT/PDGFRA Mutations in the Phase III INVICTUS Study
    Bauer, Sebastian
    Heinrich, Michael C.
    George, Suzanne
    Zalcberg, John R.
    Serrano, Cesar
    Gelderblom, Hans
    Jones, Robin L.
    Attia, Steven
    D'Amato, Gina
    Chi, Ping
    Reichardt, Peter
    Meade, Julie
    Su, Ying
    Ruiz-Soto, Rodrigo
    Blay, Jean-Yves
    von Mehren, Margaret
    Schoffski, Patrick
    [J]. CLINICAL CANCER RESEARCH, 2021, 27 (23) : 6333 - 6342
12345